Kaplan Meier postrejection patient survival in patients who developed ACR, AMR-E, or AMR-L, compared with posttransplantation patient survival in nonrejectors (NONE). The overall comparison was significantly different (log rank P = 0.016, Wilcoxon P = 0.006). Two-stratum comparisons ACR versus AMR-E and ACR versus AMR-L were NS, whereas patients with ACR had lower survival than nonrejectors (log-rank P = 0.002, Wilcoxon P = 0.0003).